Clearmind Medicine (CMND) EBT (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly EBT of -$2.0 million for Q2 2026, down 167.84% year-over-year from $3.0 million in Q2 2025, and up 46.91% quarter-over-quarter from -$3.9 million in Q1 2026.
Clearmind Medicine (CMND) EBT (2022 - 2026) Analysis & Trends
Clearmind Medicine's EBT history runs 5 years deep, the most recent figure standing at -$2.0 million for Q2 2026.
- In Q2 2026, EBT fell 167.84% year-over-year to -$2.0 million; the TTM figure through Apr 2026 stood at -$8.0 million (down 58.73% YoY), while the FY2025 annual figure was -$3.9 million, up 26.6% from the prior year.
- EBT for Q2 2026 stood at -$2.0 million, up from -$3.9 million in the prior quarter.
- The five-year high for EBT was -$581818.0 in Q3 2023, with the low at -$4.1 million in Q4 2023.
- The 5-year median for EBT is -$1.5 million (2022), against an average of -$1.6 million.
- The sharpest annual moves came in 2024 and 2026: EBT soared 71.4% in 2024, then sank 273.02% in 2026.
- Clearmind Medicine's EBT stood at -$1.6 million in 2022, then sank by 156.9% to -$4.1 million in 2023, then jumped by 71.4% to -$1.2 million in 2024, then jumped by 35.13% to -$756093.0 in 2025, then sank by 170.38% to -$2.0 million in 2026.
- Business Quant data shows CMND's EBT at -$2.0 million in Q2 2026, -$3.9 million in Q1 2026, and -$756093.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 81.49 Mn |
| 10 | Clearmind Medicine | 537,495.91 | -13.06 Mn | - | -2.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -2.04 Mn |
| Jan 31, 2026 | -3.85 Mn |
| Oct 31, 2025 | -756,093.00 |
| Jul 31, 2025 | -1.31 Mn |
| Apr 30, 2025 | -763,270.00 |
| Jan 31, 2025 | -1.03 Mn |
| Oct 31, 2024 | -1.17 Mn |
| Jul 31, 2024 | -2.05 Mn |
| Apr 30, 2024 | -871,461.00 |
| Jan 31, 2024 | -1.17 Mn |
| Oct 31, 2023 | -4.08 Mn |
| Jul 31, 2023 | -581,818.00 |
| Apr 30, 2023 | -1.53 Mn |
| Jan 31, 2023 | -1.90 Mn |
| Oct 31, 2022 | -1.59 Mn |
| Jul 31, 2022 | -1.48 Mn |
| Apr 30, 2022 | -1.84 Mn |
| Jan 31, 2022 | -1.65 Mn |